Key facts
- This page summarizes Robert Blanks's Form 4 filing for ARDELYX, INC. (ARDX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Jan 2024, 16:31.
Robert Blanks - 16 Jan 2024 Form 4 Insider Report for ARDELYX, INC. (ARDX)
- Reporting relationship
- Chief Regulatory and Quality Affairs Officer
- Issuer ticker
- ARDX
- Reported as of
- 16 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jan 2024, 16:31:53 UTC
- Prior SEC filing
- 22 Nov 2023
- Next SEC filing
- 22 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Blanks filed Form 4 for ARDELYX, INC. (ARDX) on 18 Jan 2024.
Change
- Previous filing in this sequence was filed on 22 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARDX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +112,750
- Change %
- +43%
- Price
- $0.000000
- Shares after
- 373,203
- Date
- 16 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARDX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +145,000
- Change %
- Price
- $0.000000
- Shares after
- 145,000
- Date
- 16 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 145,000
- Exercise price
- $8.78
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
Footnote F2
The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
SEC remarks
Chief Regulatory and Quality Affairs Officer